Trump administration awards contract to make COVID-19 drugs in U.S.

by reuter.com
https://ift.tt/pnED7n
U.S. President Donald Trump's administration has awarded a $354 million contract to U.S.-based Phlow Corp to manufacture drugs being tested or used to fight the new coronavirus as well as some medicines that are in shortage.

Read more

Share on Facebook Share on Twitter Share on Google Plus

About New

This is a short description in the author block about the author. You edit it by entering text in the "Biographical Info" field in the user admin panel.